Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06LAX
|
||||
Former ID |
DIB001517
|
||||
Drug Name |
PGI-02749
|
||||
Synonyms |
PGI-02749; PGI-02776; ZJ-11; ZJ-17; ZJ-43; NAAG peptidase inhibitors (brain injury, schizophrenia, pain); GCPII inhibitors (brain injury, schizophrenia, pain), PsychoGenics; Glutamate carboxypeptidase II inhibitors (brain injury, schizophrenia, pain), PsychoGenics; NAAG peptidase inhibitors (brain injury, schizophrenia, pain), PsychoGenics; N-acetylaspartylglutamate peptidase inhibitors (brain injury, schizophrenia, pain), PsychoGenics
|
||||
Indication | Brain injury [ICD10:S09.90] | Investigative | [543445] | ||
Company |
Acenta Discovery
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(=O)([C@@H](NC(=O)N[C@H](C(=O)O)CCC(=O)O)CC(C)C)O
|
||||
Target and Pathway | |||||
Target(s) | Glutamate carboxypeptidase II | Target Info | Inhibitor | [543445] | |
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
WikiPathways | One Carbon Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.